Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-009708
Filing Date
2022-09-16
Accepted
2022-09-16 16:15:12
Documents
1
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 form4-09162022_040901.html 4  
1 form4-09162022_040901.xml 4 4041
  Complete submission text file 0001415889-22-009708.txt   5381
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 221248224

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations